StockData
Bruker Corp logo

Bruker Corp (BRKRP) revenue by segment

BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30308% above fair value
$445.11+5.48 (+1.25%)

Close on Nov 17, 2026Market cap $9.52BP/E –Yield –

Bruker Corp revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
BSI CALID$1.21B$1.09B$960.40M$822.20M$819.60M$653.90M––––35.2%+10.7%
BSI NANO$1.08B$1.10B$941.90M$787.00M$697.50M$556.10M$632.70M$568.10M––31.6%-1.3%
BSI BioSpin$878.80M$905.70M$798.50M$696.70M$691.00M$600.00M$621.40M$591.10M––25.6%-3.0%
BEST$270.90M$283.00M$280.70M$237.10M$223.80M$189.50M$209.90M$194.80M$191.20M$130.20M7.9%-4.3%
Bruker NANO––––$697.50M$556.10M$632.70M$568.10M––––
Bruker CALID––––$819.60M$653.90M$623.50M$547.80M––––
BSI Life Science––––$1.51B$1.25B$1.24B$1.14B$1.07B$1.49B––
BSI Material Science––––––$632.70M$568.10M$513.00M–––
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016YoY
Unallocated Expenses$364.80M$264.90M$109.40M$72.90M––––––+37.7%
BSI CALID$262.60M$246.20M$232.10M$216.40M$227.20M$152.20M––––+6.7%
BSI BioSpin$156.50M$216.60M$211.20M$187.70M$158.20M$121.60M––––-27.7%
BSI NANO$101.10M$123.90M$158.40M$138.10M$73.40M$23.60M$40.40M$48.40M––-18.4%
BEST$26.70M$35.10M$32.50M$30.40M$22.20M$6.20M$16.40M$14.50M$7.40M$6.60M-23.9%
BSI Life Science––––$385.40M$273.80M$290.30M$244.00M$212.20M$173.50M–
BSI Material Science––––––$40.40M$48.40M$24.30M––

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
Product$2.77B$2.76B$2.46B$2.11B$2.02B$1.64B$1.74B$1.58B$1.48B$1.35B80.5%+0.3%
Service and other revenue$670.10M$607.20M$506.90M$420.80M$7.40M$6.00M$5.50M$7.30M$8.20M$11.20M19.5%+10.4%
Service––$493.80M$414.60M$393.20M$343.40M$322.40M$311.70M$278.20M$254.70M––

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
Europe excluding Germany$950.20M$873.00M$699.70M–––––––27.7%+8.8%
United States$891.30M$938.50M$777.70M$696.10M$601.00M$455.90M$529.80M$489.40M$434.70M$428.20M25.9%-5.0%
Asia Pacific excluding China$552.60M$518.50M$460.90M–––––––16.1%+6.6%
China$475.80M$471.20M$528.10M$396.50M$357.60M$313.50M––––13.8%+1.0%
Germany$297.00M$310.70M$281.50M$247.40M$262.60M$244.90M$213.60M$201.10M$200.20M$189.50M8.6%-4.4%
Other$269.60M$254.50M$216.60M$190.40M$167.10M$137.80M$173.00M$155.70M$151.20M$142.10M7.8%+5.9%
Asia Pacific––$460.90M$408.40M$371.50M$315.60M$651.00M$549.20M$514.80M$458.10M––
Rest of Europe–$873.00M$699.70M$591.90M$658.10M$519.80M$505.20M$500.20M$465.00M$393.40M––
Rest of Asia Pacific–$518.50M$460.90M$408.40M––––––––

From the segment and revenue-disaggregation notes of Bruker's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes. The KPIs tab shows these segments next to Bruker's operating metrics, with full history, charts and a link to each filing.

Operating metrics

Remaining performance obligations (RPO)FY2024FY2023FY2022FY2021FY2020FY2019FY2018YoY
Remaining performance obligations (RPO)$2.09B$2.23B$2.26B$2.08B$2.01B$1.86B$1.05B-6.1%

Counts and sizes Bruker tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each period. Breakdowns follow the company's own labels; at most 15 are shown per metric.

See a number that looks wrong?